On September 26, 2022, AIM ImmunoTech Inc. announced that it began mailing the mailer to stockholders of the Company along with copies of the Amendment No. 1 to the Company's definitive proxy statement and accompanying revised the Company proxy card, which were filed with the U.S. Securities and Exchange Commission on September 21, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.43 USD | +1.06% | -9.61% | -2.25% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.25% | 21.23M | |
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |
- Stock Market
- Equities
- AIM Stock
- News AIM ImmunoTech Inc.
- AIM ImmunoTech Solicits Proxies from Shareholders